Publication & Citation Trends
Publications
35 total
Validation of the PDACai signature in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC).
Cited by 0
Semantic Scholar
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Cited by 528
OpenAlex
Real-world outcomes in pancreatic adenocarcinoma (PDAC) and persona types with implications for standard of care (SOC) therapy (Tx).
Cited by 0
Semantic Scholar
Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.
Cited by 16
Semantic Scholar
Regional lymph node metastases oncogenic mutations compared to primary tumors in HPV+ oropharynx patients.
Cited by 0
Semantic Scholar
Identification of HPV16 genetic subtypes and sublineages in patients with HPV-positive head and neck cancer (HNC).
Cited by 0
Semantic Scholar
Rate of TP53 mutations in HPV-positive (HPV+) recurrent/metastatic head and neck cancer (RMHNC) patients.
Cited by 0
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(10)
Pancreatic and Hepatic Oncology Research
(7)
Virus-based gene therapy research
(5)
RNA Interference and Gene Delivery
(4)
Viral gastroenteritis research and epidemiology
(4)
Affiliations
Inova Health System
United States Naval Research Laboratory
National Institutes of Health
Johns Hopkins University
National Institute of Allergy and Infectious Diseases